This page was machine-translated and may differ from the original. View original

KT Supports Precision Medicine with National Cancer Center via Cloud Infrastructure

Preferred source on GooglePublished2017.05.11 18:40
KT signed a business agreement in the field of cloud and big data-based precision medicine at the National Cancer Center in Goyang, Gyeonggi-do.

Precision medicine refers to a medical service that provides diagnosis and treatment tailored to patient characteristics by integrating and analyzing patient genomic information, medical and clinical data, and lifestyle information.

Through this business agreement, KT will provide a cloud infrastructure that integrates the management of patient genomic information as well as clinical and genetic data. The National Cancer Center will focus on developing diagnostic methods and treatments for cancer patients by analyzing genomic tests on major patients with advanced cancer.

Furthermore, KT and the National Cancer Center have agreed to continue joint research and academic cooperation in the field of precision medicine, as well as technical cooperation for the construction and operation of a cloud-based cancer data center.

Lee Kang-hyun, President of the National Cancer Center, stated, “Precision medicine is a new medical paradigm that can increase the survival rate of cancer patients and reduce the socio-economic burden caused by the disease,” and added, “I hope this agreement will serve as an opportunity to take a step closer to conquering cancer through precision medicine.”
To request a correction, reply or follow-up report on this article, see how to file a request. Previously published statements are collected in corrections & replies.
김자영 Reporter

Comments